The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2015

Filed:

Apr. 20, 2012
Applicants:

Zaesung NO, Gyeonggi-do, KR;

Jaeseung Kim, Seoul, KR;

Sung-jun Han, Seoul, KR;

Jung Hwan Kim, Gyeonggi, KR;

Young Sam Park, Daejeon, KR;

Sangchul Lee, Gyeonggi-do, KR;

Kiyean Nam, Seoul, KR;

Jeongjun Kim, Seoul, KR;

Jinhwa Lee, Gyeonggi-do, KR;

Sunhee Kang, Gyeonggi-do, KR;

Min Jung Seo, Incheon, KR;

Saeyeon Lee, Gyeonggi-do, KR;

Gahee Choi, Seoul, KR;

Inventors:

Zaesung No, Gyeonggi-do, KR;

Jaeseung Kim, Seoul, KR;

Sung-Jun Han, Seoul, KR;

Jung Hwan Kim, Gyeonggi, KR;

Young Sam Park, Daejeon, KR;

Sangchul Lee, Gyeonggi-do, KR;

Kiyean Nam, Seoul, KR;

Jeongjun Kim, Seoul, KR;

Jinhwa Lee, Gyeonggi-do, KR;

Sunhee Kang, Gyeonggi-do, KR;

Min Jung Seo, Incheon, KR;

Saeyeon Lee, Gyeonggi-do, KR;

Gahee Choi, Seoul, KR;

Assignees:

Institut Pasteur Korea, Gyeonggi-Do, KR;

Qurient Co. Ltd, Gyeonggi-Do, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4353 (2006.01); C07D 491/113 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 491/113 (2013.01); A61K 31/4353 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 519/00 (2013.01);
Abstract

The present invention refers to: a compound having the general formula (I), wherein n is 0, 1, 2 or; m is 0, 1, 2 or 3; o is 0, 1, 2 or 3; W, X, Y and Z are independently selected from CH, N or N-oxide; A is NR, C═O, C═S, OP(O)(O), P═O, CH2, or a heteroarly selected from the group consisting of (a), (b), (c), (d), (e), (f), (g); V is C═O, O, S, CH, or NR; as well as its use in treating inflammatory diseases such as asthma, COPD, inflammation post infection, arthritis, atherosclerosis, pain and dermatitis.


Find Patent Forward Citations

Loading…